{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:08:06Z","timestamp":1787224086606,"version":"build-2736575974"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s43032-022-01064-0","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T14:02:59Z","timestamp":1660572179000},"page":"1383-1398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma"],"prefix":"10.1007","volume":"30","author":[{"given":"Anusha Shreenidhi","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningthoujam Anirudh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emdormi","family":"Rymbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Birendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Jayaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-6583","authenticated-orcid":false,"given":"Divakar","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"issue":"2","key":"1064_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0037-1599090","volume":"35","author":"MM McWilliams","year":"2017","unstructured":"McWilliams MM, Chennathukuzhi VM. Recent advances in uterine fibroid etiology. Semin Reprod Med. 2017;35(2):181\u20139. https:\/\/doi.org\/10.1055\/s-0037-1599090.","journal-title":"Semin Reprod Med"},{"key":"1064_CR2","doi-asserted-by":"publisher","first-page":"539365","DOI":"10.1155\/2012\/539365","volume":"2012","author":"D Simms-Stewart","year":"2012","unstructured":"Simms-Stewart D, Fletcher H. Counselling patients with uterine fibroids: a review of the management and complications. Obstet Gynecol Int. 2012;2012:539365. https:\/\/doi.org\/10.1155\/2012\/539365.","journal-title":"Obstet Gynecol Int"},{"issue":"9","key":"1064_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1111\/jog.14343","volume":"46","author":"GR P\u00e9rez-Roncero","year":"2020","unstructured":"P\u00e9rez-Roncero GR, L\u00f3pez-Baena MT, Ornat L, Cuerva MJ, Garcia-Casarrubios P, Chedraui P, et al. Uterine fibroids and preterm birth risk: a systematic review and meta-analysis. J Obstet Gynaecol Res. 2020;46(9):1711\u201327. https:\/\/doi.org\/10.1111\/jog.14343.","journal-title":"J Obstet Gynaecol Res"},{"issue":"12","key":"1064_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/jog.13437","volume":"43","author":"GN Milazzo","year":"2017","unstructured":"Milazzo GN, Catalano A, Badia V, Mallozzi M, Caserta D. Myoma and myomectomy: poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017;43(12):1789\u2013804. https:\/\/doi.org\/10.1111\/jog.13437.","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"1064_CR5","doi-asserted-by":"publisher","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1-211.e9. https:\/\/doi.org\/10.1016\/j.ajog.2011.12.002.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1064_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0030-1251476","volume":"28","author":"N Chegini","year":"2010","unstructured":"Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28(3):180\u2013203. https:\/\/doi.org\/10.1055\/s-0030-1251476.","journal-title":"Semin Reprod Med"},{"issue":"18","key":"1064_CR7","doi-asserted-by":"publisher","first-page":"e99911","DOI":"10.1172\/jci.insight.99911","volume":"3","author":"DS Foster","year":"2018","unstructured":"Foster DS, Jones RE, Ransom RC, Longaker MT, Norton JA. The evolving relationship of wound healing and tumor stroma. JCI Insight. 2018;3(18):e99911. https:\/\/doi.org\/10.1172\/jci.insight.99911.","journal-title":"JCI Insight"},{"issue":"7","key":"1064_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1152\/physiolgenomics.00158.2013","volume":"46","author":"B Rybinski","year":"2014","unstructured":"Rybinski B, Franco-Barraza J, Cukierman E. The wound healing, chronic fibrosis, and cancer progression triad. Physiol Genomics. 2014;46(7):223\u201344. https:\/\/doi.org\/10.1152\/physiolgenomics.00158.2013.","journal-title":"Physiol Genomics"},{"issue":"2","key":"1064_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.20517\/2394-4722.2016.08","volume":"18","author":"G-F Xiong","year":"2016","unstructured":"Xiong G-F, Xu R. Function of cancer cell-derived extracellular matrix in tumor progression. J Cancer Metastasis Treat. 2016;18(2):357\u201364. https:\/\/doi.org\/10.20517\/2394-4722.2016.08.","journal-title":"J Cancer Metastasis Treat"},{"issue":"10","key":"1064_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/14728222.2017.1370455","volume":"21","author":"L Juillerat-Jeanneret","year":"2017","unstructured":"Juillerat-Jeanneret L, Tafelmeyer P, Golshayan D. Fibroblast activation protein-\u03b1 in fibrogenic disorders and cancer: more than a prolyl-specific peptidase? Expert Opin Ther Targets. 2017;21(10):977\u201391. https:\/\/doi.org\/10.1080\/14728222.2017.1370455.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"1064_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s43032-019-00106-4","volume":"27","author":"MKP Purdy","year":"2020","unstructured":"Purdy MKP, Ducharme M, Haak AJ, Ravix J, Tan Q, Sicard D, et al. YAP\/TAZ are activated by mechanical and hormonal stimuli in myometrium and exhibit increased baseline activation in uterine fibroids. Reprod Sci. 2020;27(4):1074\u201385. https:\/\/doi.org\/10.1007\/s43032-019-00106-4.","journal-title":"Reprod Sci"},{"issue":"3","key":"1064_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cei.12757","volume":"184","author":"L Wagner","year":"2016","unstructured":"Wagner L, Klemann C, Stephan M, Von H\u00f6rsten S. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and\/or structure homologue (DASH) proteins. Clin Exp Immunol. 2016;184(3):265\u201383. https:\/\/doi.org\/10.1111\/cei.12757.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1064_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1742-4658.2009.07526.x","volume":"277","author":"DMT Yu","year":"2010","unstructured":"Yu DMT, Yao TW, Chowdhury S, Nadvi NA, Osborne B, Church WB, et al. The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J. 2010;277(5):1126\u201344. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07526.x.","journal-title":"FEBS J"},{"issue":"51","key":"1064_CR14","doi-asserted-by":"publisher","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","volume":"274","author":"JE Park","year":"1999","unstructured":"Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274(51):36505\u201312. https:\/\/doi.org\/10.1074\/jbc.274.51.36505.","journal-title":"J Biol Chem"},{"issue":"3","key":"1064_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","volume":"163","author":"N Luo","year":"2014","unstructured":"Luo N, Guan Q, Zheng L, Qu X, Dai H, Cheng Z. Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res. 2014;163(3):232\u201341. https:\/\/doi.org\/10.1016\/j.trsl.2013.11.008.","journal-title":"Transl Res"},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.12688\/f1000research.12172.1","volume":"6","author":"ARW Williams","year":"2017","unstructured":"Williams ARW. Uterine fibroids - What\u2019s new? F1000Research. 2017;6:2109. https:\/\/doi.org\/10.12688\/f1000research.12172.1.","journal-title":"F1000Research"},{"key":"1064_CR17","doi-asserted-by":"publisher","first-page":"2414609","DOI":"10.1155\/2018\/2414609","volume":"2018","author":"TD Lewis","year":"2018","unstructured":"Lewis TD, Malik M, Britten J, San Pablo AMA, Catherino WH. A comprehensive review of the pharmacologic management of uterine leiomyoma. Biomed Res Int. 2018;2018:2414609. https:\/\/doi.org\/10.1155\/2018\/2414609.","journal-title":"Biomed Res Int"},{"issue":"7","key":"1064_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/jog.14002","volume":"45","author":"MM Dolmans","year":"2019","unstructured":"Dolmans MM, Donnez J, Fellah L. Uterine fibroid management: today and tomorrow. J Obstet Gynaecol Res. 2019;45(7):1222\u20139. https:\/\/doi.org\/10.1111\/jog.14002.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"1064_CR19","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.fertnstert.2014.07.1253","volume":"102","author":"M Luyckx","year":"2014","unstructured":"Luyckx M, Squifflet JL, Jadoul P, Votino R, Dolmans MM, Donnez J. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertil Steril. 2014;102(5):1404\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.07.1253.","journal-title":"Fertil Steril"},{"issue":"6","key":"1064_CR20","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1210\/clinem\/dgab081","volume":"106","author":"EL Yoon","year":"2021","unstructured":"Yoon EL, Yuk JS. Use of ulipristal acetate and risk of liver disease: a nationwide cohort study. J Clin Endocrinol Metab. 2021;106(6):1773\u201382. https:\/\/doi.org\/10.1210\/clinem\/dgab081.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1064_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2119\/molmed.2014.00053","volume":"21","author":"MA Borahay","year":"2015","unstructured":"Borahay MA, Al Hendy A, Kilic GS, Boehning D. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Mol Med. 2015;21(1):242\u201356. https:\/\/doi.org\/10.2119\/molmed.2014.00053.","journal-title":"Mol Med"},{"issue":"3","key":"1064_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-0030-1251482","volume":"28","author":"L Yu","year":"2010","unstructured":"Yu L, Moore AB, Dixon D. Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma. Semin Reprod Med. 2010;28(3):250\u20139. https:\/\/doi.org\/10.1055\/s-0030-1251482.","journal-title":"Semin Reprod Med"},{"issue":"42","key":"1064_CR23","doi-asserted-by":"publisher","first-page":"17053","DOI":"10.1073\/pnas.1313650110","volume":"110","author":"M Ono","year":"2013","unstructured":"Ono M, Yin P, Navarro A, Moravek MB, Coon VJS, Druschitz SA, et al. Paracrine activation of WNT\/\u03b2-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U S A. 2013;110(42):17053\u20138. https:\/\/doi.org\/10.1073\/pnas.1313650110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1064_CR24","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3390\/ijms18112435","volume":"18","author":"MWM Ciebiera","year":"2017","unstructured":"Ciebiera MWM, Wrzosek M, M\u0119czekalski B, Nowicka G, \u0141ukaszuk K, Ciebiera M, et al. Role of transforming growth factor \u03b2 in uterine fibroid biology. Int J Mol Sci. 2017;18(11):2435. https:\/\/doi.org\/10.3390\/ijms18112435.","journal-title":"Int J Mol Sci"},{"key":"1064_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4\u201327. https:\/\/doi.org\/10.1016\/j.addr.2015.11.001.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1064_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1530\/REP-16-0216","volume":"152","author":"SJ Holdsworth-Carson","year":"2016","unstructured":"Holdsworth-Carson SJ, Zhao D, Cann L, Bittinger S, Nowell CJ, Rogers PAW. Differences in the cellular composition of small versus large uterine fibroids. Reproduction. 2016;152(5):467\u201380. https:\/\/doi.org\/10.1530\/REP-16-0216.","journal-title":"Reproduction"},{"issue":"2","key":"1064_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3892\/ol.2014.2225","volume":"8","author":"LH Zheng","year":"2014","unstructured":"Zheng LH, Cai FF, Ge I, Biskup E, Cheng ZP. Stromal fibroblast activation and their potential association with uterine fibroids. Oncol Lett. 2014;8(2):479\u201386. https:\/\/doi.org\/10.3892\/ol.2014.2225.","journal-title":"Oncol Lett"},{"issue":"1","key":"1064_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13578-019-0362-3","volume":"9","author":"A Vall\u00e9e","year":"2019","unstructured":"Vall\u00e9e A, Lecarpentier Y. TGF-\u03b2 in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell Biosci. 2019;9(1):98. https:\/\/doi.org\/10.1186\/s13578-019-0362-3.","journal-title":"Cell Biosci"},{"issue":"5","key":"1064_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/cells10050982","volume":"10","author":"A Zannotti","year":"2021","unstructured":"Zannotti A, Greco S, Pellegrino P, Giantomassi F, Carpini GD, Goteri G, et al. Macrophages and immune responses in uterine fibroids. Cells. 2021;10(5):982. https:\/\/doi.org\/10.3390\/cells10050982.","journal-title":"Cells"},{"issue":"4","key":"1064_CR30","doi-asserted-by":"publisher","first-page":"e0215646","DOI":"10.1371\/journal.pone.0215646","volume":"14","author":"FL Jayes","year":"2019","unstructured":"Jayes FL, Liu B, Feng L, Aviles-Espinoza N, Leikin S, Leppert PC. Evidence of biomechanical and collagen heterogeneity in uterine fibroids. PLoS One. 2019;14(4):e0215646. https:\/\/doi.org\/10.1371\/journal.pone.0215646.","journal-title":"PLoS One"},{"issue":"2","key":"1064_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jmb.2006.07.014","volume":"362","author":"J Bella","year":"2006","unstructured":"Bella J, Liu J, Kramer R, Brodsky B, Berman HM. Conformational effects of Gly-X-Gly interruptions in the collagen triple helix. J Mol Biol. 2006;362(2):298\u2013311. https:\/\/doi.org\/10.1016\/j.jmb.2006.07.014.","journal-title":"J Mol Biol"},{"key":"1064_CR32","doi-asserted-by":"publisher","first-page":"783289","DOI":"10.1155\/2014\/783289","volume":"2014","author":"PC Leppert","year":"2014","unstructured":"Leppert PC, Jayes FL, Segars JH. The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstet Gynecol Int. 2014;2014:783289. https:\/\/doi.org\/10.1155\/2014\/783289.","journal-title":"Obstet Gynecol Int"},{"issue":"1","key":"1064_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3160001","volume":"316","author":"KE Kadler","year":"1996","unstructured":"Kadler KE, Holmes DF, Trotter JA, Chapman JA. Collagen fibril formation. Biochem J. 1996;316(1):1\u201311. https:\/\/doi.org\/10.1042\/bj3160001.","journal-title":"Biochem J"},{"key":"1064_CR34","doi-asserted-by":"publisher","first-page":"5316845","DOI":"10.1155\/2017\/5316845","volume":"2017","author":"M Kamel","year":"2017","unstructured":"Kamel M, Wagih M, Kilic GS, Diaz-Arrastia CR, Baraka MA, Salama SA. Overhydroxylation of lysine of collagen increases uterine fibroids proliferation: roles of lysyl hydroxylases, lysyl oxidases, and matrix metalloproteinases. Biomed Res Int. 2017;2017:5316845. https:\/\/doi.org\/10.1155\/2017\/5316845.","journal-title":"Biomed Res Int"},{"issue":"6","key":"1064_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/molehr\/8.6.559","volume":"8","author":"V Metaxa-Mariatou","year":"2002","unstructured":"Metaxa-Mariatou V, McGavigan CJ, Robertson K, Stewart C, Cameron IT, Campbell S. Elastin distribution in the myometrial and vascular smooth muscle of the human uterus. Mol Hum Reprod. 2002;8(6):559\u201365. https:\/\/doi.org\/10.1093\/molehr\/8.6.559.","journal-title":"Mol Hum Reprod"},{"key":"1064_CR36","doi-asserted-by":"publisher","first-page":"596702","DOI":"10.3389\/fcell.2021.596702","volume":"9","author":"K Wang","year":"2021","unstructured":"Wang K, Meng X, Guo Z. Elastin structure, synthesis, regulatory mechanism and relationship with cardiovascular diseases. Front Cell Dev Biol. 2021;9:596702. https:\/\/doi.org\/10.3389\/fcell.2021.596702.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"1064_CR37","first-page":"115","volume":"28","author":"WQ Zheng","year":"2006","unstructured":"Zheng WQ, Ma R, Zheng JM, Gong ZJ. Elastin distribution in the normal uterus, uterine leiomyomas, adenomyosis and adenomyomas: a comparison. Anal Quant Cytol Histol. 2006;28(2):115\u201320.","journal-title":"Anal Quant Cytol Histol"},{"issue":"1","key":"1064_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/humupd\/dmx032","volume":"24","author":"MS Islam","year":"2018","unstructured":"Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24(1):59\u201385. https:\/\/doi.org\/10.1093\/humupd\/dmx032.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"1064_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1590\/S1516-8913201500281","volume":"58","author":"GB de Oliveira","year":"2015","unstructured":"de Oliveira GB, do Vale AM, dos Santos AC, de Moura CEB, de Rocha HA, de Oliveira MF. Composition and significance of glycosaminoglycans in the uterus and placenta of mammals. Brazilian Arch Biol Technol. 2015;58(4):512\u201320. https:\/\/doi.org\/10.1590\/S1516-8913201500281.","journal-title":"Brazilian Arch Biol Technol"},{"issue":"7","key":"1064_CR40","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1210\/en.2018-00151","volume":"159","author":"MFB Jamaluddin","year":"2018","unstructured":"Jamaluddin MFB, Nahar P, Tanwar PS. Proteomic characterization of the extracellular matrix of human uterine fibroids. Endocrinology. 2018;159(7):2656\u201369. https:\/\/doi.org\/10.1210\/en.2018-00151.","journal-title":"Endocrinology"},{"issue":"735","key":"1064_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature10152","volume":"474","author":"M Shi","year":"2011","unstructured":"Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, et al. Latent TGF-\u03b2 structure and activation. Nature. 2011;474(735):343\u201351. https:\/\/doi.org\/10.1038\/nature10152.","journal-title":"Nature"},{"key":"1064_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1479-5876-10-183","volume":"10","author":"L Kubiczkova","year":"2012","unstructured":"Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. TGF-\u03b2 - an excellent servant but a bad master. J Transl Med. 2012;10:183. https:\/\/doi.org\/10.1186\/1479-5876-10-183.","journal-title":"J Transl Med"},{"issue":"2","key":"1064_CR43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/bcr43","volume":"2","author":"J Donovan","year":"2000","unstructured":"Donovan J, Slingerland J. Transforming growth factor-\u03b2 and breast cancer: cell cycle arrest by transforming growth factor-\u03b2 and its disruption in cancer. Breast Cancer Res. 2000;2(2):116\u201324. https:\/\/doi.org\/10.1186\/bcr43.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1064_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/2049-1891-5-52","volume":"5","author":"Q Li","year":"2014","unstructured":"Li Q. Transforming growth factor \u03b2 signaling in uterine development and function. J Anim Sci Biotechnol. 2014;5(1):52. https:\/\/doi.org\/10.1186\/2049-1891-5-52.","journal-title":"J Anim Sci Biotechnol"},{"issue":"8","key":"1064_CR45","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/emboj\/19.8.1745","volume":"19","author":"J Massagu\u00e9","year":"2000","unstructured":"Massagu\u00e9 J, Wotton D. Transcriptional control by the TGF-\u03b2\/Smad signaling system. EMBO J. 2000;19(8):1745\u201354. https:\/\/doi.org\/10.1093\/emboj\/19.8.1745.","journal-title":"EMBO J"},{"issue":"2\u20133","key":"1064_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0143-4004(97)90085-0","volume":"18","author":"CH Graham","year":"1997","unstructured":"Graham CH. Effect of transforming growth factor-\u03b2 on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta. 1997;18(2\u20133):137\u201343. https:\/\/doi.org\/10.1016\/S0143-4004(97)90085-0.","journal-title":"Placenta"},{"issue":"3","key":"1064_CR47","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/dvdy.24554","volume":"247","author":"JF Santibanez","year":"2018","unstructured":"Santibanez JF, Obradovi\u0107 H, Kukolj T, Krsti\u0107 J. Transforming growth factor-\u03b2, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition. Dev Dyn. 2018;247(3):382\u201395. https:\/\/doi.org\/10.1002\/dvdy.24554.","journal-title":"Dev Dyn"},{"issue":"2","key":"1064_CR48","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1210\/jcem.86.2.7237","volume":"86","author":"B-S Lee","year":"2001","unstructured":"Lee B-S, Nowak RA. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-\u03b23 (TGF\u03b23) and altered responses to the antiproliferative effects of TGF\u03b2 1. J Clin Endocrinol Metab. 2001;86(2):913\u201320. https:\/\/doi.org\/10.1210\/jcem.86.2.7237.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"1064_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2003.08.007","volume":"209","author":"N Chegini","year":"2003","unstructured":"Chegini N, Luo X, Ding L, Ripley D. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol. 2003;209(1\u20132):9\u201316. https:\/\/doi.org\/10.1016\/j.mce.2003.08.007.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1064_CR50","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1083\/jcb.142.3.873","volume":"142","author":"G Serini","year":"1998","unstructured":"Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-\u03b21. J Cell Biol. 1998;142(3):873\u201381. https:\/\/doi.org\/10.1083\/jcb.142.3.873.","journal-title":"J Cell Biol"},{"issue":"1","key":"1064_CR51","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbadis.2016.11.006","volume":"1863","author":"AV Shinde","year":"2017","unstructured":"Shinde AV, Humeres C, Frangogiannis NG. The role of \u03b1-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta - Mol Basis Dis. 2017;1863(1):298\u2013309. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.006.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"issue":"1","key":"1064_CR52","doi-asserted-by":"publisher","first-page":"jcs209619","DOI":"10.1242\/jcs.209619","volume":"131","author":"E Ventura","year":"2018","unstructured":"Ventura E, Weller M, Macnair W, Eschbach K, Beisel C, Cordazzo C, et al. TGF-\u03b2 induces oncofetal fibronectin that, in turn, modulates TGF-\u03b2 superfamily signaling in endothelial cells. J Cell Sci. 2018;131(1):jcs209619. https:\/\/doi.org\/10.1242\/jcs.209619.","journal-title":"J Cell Sci"},{"key":"1064_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.matbio.2014.11.004","volume":"41","author":"AV Shinde","year":"2015","unstructured":"Shinde AV, Kelsh R, Peters JH, Sekiguchi K, Van De Water L, McKeown-Longo PJ. The \u03b14\u03b21 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts. Matrix Biol. 2015;41:26\u201335. https:\/\/doi.org\/10.1016\/j.matbio.2014.11.004.","journal-title":"Matrix Biol"},{"key":"1064_CR54","doi-asserted-by":"publisher","DOI":"10.1017\/s1462399411001967","volume":"13","author":"K Kis","year":"2011","unstructured":"Kis K, Liu X, Hagood JS. Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med. 2011;13: e27. https:\/\/doi.org\/10.1017\/s1462399411001967.","journal-title":"Expert Rev Mol Med"},{"issue":"7","key":"1064_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a005041","volume":"3","author":"JE Schwarzbauer","year":"2011","unstructured":"Schwarzbauer JE, DeSimone DW. Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb Perspect Biol. 2011;3(7):1\u201319. https:\/\/doi.org\/10.1101\/cshperspect.a005041.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"1064_CR56","doi-asserted-by":"publisher","first-page":"jcs201293","DOI":"10.1242\/jcs.201293","volume":"131","author":"F Klingberg","year":"2018","unstructured":"Klingberg F, Chau G, Walraven M, Boo S, Koehler A, Chow ML, et al. The fibronectin ED-A domain enhances recruitment of latent TGF-\u03b2-binding protein-1 to the fibroblast matrix. J Cell Sci. 2018;131(5):jcs201293. https:\/\/doi.org\/10.1242\/jcs.201293.","journal-title":"J Cell Sci"},{"issue":"6","key":"1064_CR57","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.fertnstert.2020.12.022","volume":"115","author":"C Bernacchioni","year":"2021","unstructured":"Bernacchioni C, Ciarmela P, Vannuzzi V, Greco S, Vannuccini S, Malentacchi F, et al. Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect. Fertil Steril. 2021;115(6):1576\u201385. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.12.022.","journal-title":"Fertil Steril"},{"issue":"23","key":"1064_CR58","doi-asserted-by":"publisher","first-page":"14850","DOI":"10.1074\/jbc.272.23.14850","volume":"272","author":"S Lawler","year":"1997","unstructured":"Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold-Prenner I, et al. The type II transforming growth factor-\u03b2 receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem. 1997;272(23):14850\u20139. https:\/\/doi.org\/10.1074\/jbc.272.23.14850.","journal-title":"J Biol Chem"},{"issue":"8","key":"1064_CR59","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1158\/0008-5472.CAN-06-3851","volume":"67","author":"AJ Galliher","year":"2007","unstructured":"Galliher AJ, Schiemann WP. Src phosphorylates Tyr284 in TGF-\u03b2 type II receptor and regulates TGF-\u03b2 stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res. 2007;67(8):3752\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3851.","journal-title":"Cancer Res"},{"issue":"17","key":"1064_CR60","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","volume":"26","author":"MK Lee","year":"2007","unstructured":"Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, et al. TGF-\u03b2 activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 2007;26(17):3957\u201367. https:\/\/doi.org\/10.1038\/sj.emboj.7601818.","journal-title":"EMBO J"},{"issue":"2","key":"1064_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.krcp.2012.04.322","volume":"31","author":"S Kim II","year":"2012","unstructured":"Kim S II, Choi ME. TGF-\u03b2-activated kinase-1: new insights into the mechanism of TGF-\u03b2 signaling and kidney disease. Kidney Res Clin Pract. 2012;31(2):94\u2013105. https:\/\/doi.org\/10.1016\/j.krcp.2012.04.322.","journal-title":"Kidney Res Clin Pract"},{"issue":"3","key":"1064_CR62","doi-asserted-by":"publisher","first-page":"22285","DOI":"10.1074\/jbc.M109.007146","volume":"284","author":"S Kim II","year":"2009","unstructured":"Kim S II, Kwak JH, Na HJ, Kim JK, Ding Y, Choi ME. Transforming growth factor-\u03b2(TGF-\u03b21) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-\u03b2receptor kinase activity in mesangial cells. J Biol Chem. 2009;284(3):22285\u201396. https:\/\/doi.org\/10.1074\/jbc.M109.007146.","journal-title":"J Biol Chem"},{"issue":"3","key":"1064_CR63","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.semnephrol.2012.04.003","volume":"32","author":"ME Choi","year":"2012","unstructured":"Choi ME, Ding Y, Kim S II. TGF-\u03b2 signaling via TAK1 pathway: role in kidney fibrosis. Semin Nephrol. 2012;32(3):244\u201352. https:\/\/doi.org\/10.1016\/j.semnephrol.2012.04.003.","journal-title":"Semin Nephrol"},{"issue":"10","key":"1064_CR64","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ncb1780","volume":"10","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A, Thakur N, Grimsby S, Marcusson A, Von Bulow V, Schuster N, et al. The type I TGF-\u03b2 receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol. 2008;10(10):1199\u2013207. https:\/\/doi.org\/10.1038\/ncb1780.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"1064_CR65","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/onc.2012.171","volume":"32","author":"C Freudlsperger","year":"2013","unstructured":"Freudlsperger C, Bian Y, Contag WS, Burnett J, Coupar J, Yang X, et al. TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2013;32(12):1549\u201359. https:\/\/doi.org\/10.1038\/onc.2012.171.","journal-title":"Oncogene"},{"issue":"2","key":"1064_CR66","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1158\/0008-5472.CAN-13-2702","volume":"75","author":"JJ Wamsley","year":"2015","unstructured":"Wamsley JJ, Kumar M, Allison DF, Clift SH, Holzknecht CM, Szymura SJ, et al. Activin upregulation by NF-\u03baB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer. Cancer Res. 2015;75(2):426\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2702.","journal-title":"Cancer Res"},{"issue":"1","key":"1064_CR67","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1038\/s41467-020-16409-z","volume":"11","author":"MS Wietecha","year":"2020","unstructured":"Wietecha MS, Pensalfini M, Cangkrama M, M\u00fcller B, Jin J, Brinckmann J, et al. Activin-mediated alterations of the fibroblast transcriptome and matrisome control the biomechanical properties of skin wounds. Nat Commun. 2020;11(1):2604. https:\/\/doi.org\/10.1038\/s41467-020-16409-z.","journal-title":"Nat Commun"},{"issue":"12","key":"1064_CR68","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tibs.2013.10.001","volume":"38","author":"L Zhang","year":"2013","unstructured":"Zhang L, Zhou F, ten Dijke P. Signaling interplay between transforming growth factor-\u03b2 receptor and PI3K\/AKT pathways in cancer. Trends Biochem Sci. 2013;38(12):612\u201320. https:\/\/doi.org\/10.1016\/j.tibs.2013.10.001.","journal-title":"Trends Biochem Sci"},{"issue":"21","key":"1064_CR69","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.1128\/mcb.21.21.7218-7230.2001","volume":"21","author":"F Vi\u00f1als","year":"2001","unstructured":"Vi\u00f1als F, Pouyss\u00e9gur J. Transforming Growth Factor \u03b21 (TGF-\u03b21) Promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-\u03b1 signaling. Mol Cell Biol. 2001;21(21):7218\u201330. https:\/\/doi.org\/10.1128\/mcb.21.21.7218-7230.2001.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"1064_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/09513590.2011.583955","volume":"28","author":"A Makker","year":"2012","unstructured":"Makker A, Goel MM, Das V, Agarwal A. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol. 2012;28(3):175\u201381. https:\/\/doi.org\/10.3109\/09513590.2011.583955.","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"1064_CR71","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/carcin\/bgq155","volume":"31","author":"A Lasfar","year":"2010","unstructured":"Lasfar A, Cohen-Solal KA. Resistance to transforming growth factor \u03b2-mediated tumor suppression in melanoma: are multiple mechanisms in place? Carcinogenesis. 2010;31(10):1710\u20137. https:\/\/doi.org\/10.1093\/carcin\/bgq155.","journal-title":"Carcinogenesis"},{"issue":"2","key":"1064_CR72","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0092-8674(04)00298-3","volume":"117","author":"J Seoane","year":"2004","unstructured":"Seoane J, Van LH, Shen L, Anderson SA, Massagu\u00e9 J. Integration of smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 2004;117(2):211\u201323. https:\/\/doi.org\/10.1016\/S0092-8674(04)00298-3.","journal-title":"Cell"},{"issue":"5","key":"1064_CR73","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","volume":"73","author":"A Arici","year":"2000","unstructured":"Arici A, Sozen I. Transforming growth factor-\u03b23 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril. 2000;73(5):1006\u201311. https:\/\/doi.org\/10.1016\/S0015-0282(00)00418-0.","journal-title":"Fertil Steril"},{"issue":"10","key":"1064_CR74","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-06-1811","volume":"13","author":"NJ Laping","year":"2007","unstructured":"Laping NJ, Everitt JI, Frazier KS, Burgert M, Portis MJ, Cadacio C, et al. Tumor-specific efficacy of transforming growth factor-\u03b2RI inhibition in eker rats. Clin Cancer Res. 2007;13(10):3087\u201399. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1811.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1064_CR75","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1165\/ajrcmb.21.6.3720","volume":"21","author":"HY Zhang","year":"1999","unstructured":"Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor \u03b21. Am J Respir Cell Mol Biol. 1999;21(6):658\u201365. https:\/\/doi.org\/10.1165\/ajrcmb.21.6.3720.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1064_CR76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1478-811X-8-10","volume":"8","author":"AB Moore","year":"2010","unstructured":"Moore AB, Yu L, Swartz CD, Zheng X, Wang L, Castro L, et al. Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type i production, and activate RTKs and TGF beta receptor signaling in co-culture. Cell Commun Signal. 2010;8:10. https:\/\/doi.org\/10.1186\/1478-811X-8-10.","journal-title":"Cell Commun Signal"},{"issue":"9","key":"1064_CR77","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.jbiomech.2014.03.031","volume":"47","author":"D Duscher","year":"2014","unstructured":"Duscher D, Maan ZN, Wong VW, Rennert RC, Januszyk M, Rodrigues M, et al. Mechanotransduction and fibrosis. J Biomech. 2014;47(9):1997\u20132005. https:\/\/doi.org\/10.1016\/j.jbiomech.2014.03.031.","journal-title":"J Biomech"},{"issue":"5","key":"1064_CR78","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","volume":"8","author":"Y Takada","year":"2007","unstructured":"Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007;8(5):215. https:\/\/doi.org\/10.1186\/gb-2007-8-5-215.","journal-title":"Genome Biol"},{"issue":"7","key":"1064_CR79","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1182\/blood-2007-03-080077","volume":"110","author":"J Zhu","year":"2007","unstructured":"Zhu J, Carman CV, Kim M, Shimaoka M, Springer TA, Luo BH. Requirement of \u03b1 and \u03b2 subunit transmembrane helix separation for integrin outside-in signaling. Blood. 2007;110(7):2475\u201383. https:\/\/doi.org\/10.1182\/blood-2007-03-080077.","journal-title":"Blood"},{"issue":"7","key":"1064_CR80","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1083\/jcb.201212037","volume":"201","author":"J Zhu","year":"2013","unstructured":"Zhu J, Zhu J, Springer TA. Complete integrin headpiece opening in eight steps. J Cell Biol. 2013;201(7):1053\u201368. https:\/\/doi.org\/10.1083\/jcb.201212037.","journal-title":"J Cell Biol"},{"issue":"9","key":"1064_CR81","doi-asserted-by":"publisher","first-page":"e75844","DOI":"10.1371\/journal.pone.0075844","volume":"8","author":"F Koohestani","year":"2013","unstructured":"Koohestani F, Braundmeier AG, Mahdian A, Seo J, Bi JJ, Nowak RA. Extracellular matrix collagen alters cell proliferation and cell cycle progression of human uterine leiomyoma smooth muscle cells. PLoS One. 2013;8(9):e75844. https:\/\/doi.org\/10.1371\/journal.pone.0075844.","journal-title":"PLoS One"},{"issue":"1","key":"1064_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.fertnstert.2020.12.011","volume":"116","author":"CN Cordeiro Mitchell","year":"2021","unstructured":"Cordeiro Mitchell CN, Islam MS, Afrin S, Brennan J, Psoter KJ, Segars JH. Mechanical stiffness augments ligand-dependent progesterone receptor B activation via MEK 1\/2 and Rho\/ROCK\u2013dependent signaling pathways in uterine fibroid cells. Fertil Steril. 2021;116(1):255\u201365. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.12.011.","journal-title":"Fertil Steril"},{"issue":"3","key":"1064_CR83","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1210\/jc.2018-01216","volume":"104","author":"SSM Ng","year":"2019","unstructured":"Ng SSM, Jorge S, Malik M, Britten J, Su SC, Armstrong CR, et al. A-kinase anchoring protein 13 (AKAP13) augments progesterone signaling in uterine fibroid cells. J Clin Endocrinol Metab. 2019;104(3):970\u201380. https:\/\/doi.org\/10.1210\/jc.2018-01216.","journal-title":"J Clin Endocrinol Metab"},{"key":"1064_CR84","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-030-35582-1_6","volume":"1223","author":"S Porazinski","year":"2020","unstructured":"Porazinski S, Parkin A, Pajic M. Rho-ROCK signaling in normal physiology and as a key player in shaping the tumor microenvironment. Adv Exp Med Biol. 2020;1223:99\u2013127.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"1064_CR85","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1055\/s-0037-1607268","volume":"35","author":"S Rafique","year":"2017","unstructured":"Rafique S, Segars JH, Leppert PC. Mechanical signaling and extracellular matrix in uterine fibroids. Semin Reprod Med. 2017;35(6):487\u201393. https:\/\/doi.org\/10.1055\/s-0037-1607268.","journal-title":"Semin Reprod Med"},{"issue":"8\u20139","key":"1064_CR86","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","volume":"87","author":"PJ Wipff","year":"2008","unstructured":"Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor \u03b21 - an intimate relationship. Eur J Cell Biol. 2008;87(8\u20139):601\u201315. https:\/\/doi.org\/10.1016\/j.ejcb.2008.01.012.","journal-title":"Eur J Cell Biol"},{"key":"1064_CR87","doi-asserted-by":"publisher","first-page":"jcs230425","DOI":"10.1242\/jcs.230425","volume":"133","author":"A Pocaterra","year":"2020","unstructured":"Pocaterra A, Romani P, Dupont S. YAP\/TAZ functions and their regulation at a glance. J Cell Sci. 2020;133:jcs230425. https:\/\/doi.org\/10.1242\/jcs.230425.","journal-title":"J Cell Sci"},{"issue":"1","key":"1064_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30(1):1\u201317. https:\/\/doi.org\/10.1101\/gad.274027.115.","journal-title":"Genes Dev"},{"issue":"7","key":"1064_CR89","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1002\/ctm2.475","volume":"11","author":"MS Islam","year":"2021","unstructured":"Islam MS, Afrin S, Singh B, Jayes FL, Brennan JT, Borahay MA, et al. Extracellular matrix and Hippo signaling as therapeutic targets of anti-fibrotic compounds for uterine fibroids. Clin Transl Med. 2021;11(7):e475. https:\/\/doi.org\/10.1002\/ctm2.475.","journal-title":"Clin Transl Med"},{"issue":"4","key":"1064_CR90","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jsgi.2006.02.008","volume":"13","author":"M De Falco","year":"2006","unstructured":"De Falco M, Staibano S, D\u2019Armiento FP, Mascolo M, Salvatore G, Busiello A, et al. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-\u03b23 and connective tissue growth factor. J Soc Gynecol Investig. 2006;13(4):297\u2013303. https:\/\/doi.org\/10.1016\/j.jsgi.2006.02.008.","journal-title":"J Soc Gynecol Investig"},{"issue":"S1","key":"1064_CR91","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1186\/1755-1536-5-s1-s24","volume":"5","author":"KE Lipson","year":"2012","unstructured":"Lipson KE, Wong C, Teng Y, Spong S. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012;5(S1):S24. https:\/\/doi.org\/10.1186\/1755-1536-5-s1-s24.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"2","key":"1064_CR92","doi-asserted-by":"publisher","first-page":"e88772","DOI":"10.1371\/journal.pone.0088772","volume":"9","author":"KM Chung","year":"2014","unstructured":"Chung KM, Hsu SC, Chu YR, Lin MY, Jiaang WT, Chen RH, et al. Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation. PLoS One. 2014;9(2):e88772. https:\/\/doi.org\/10.1371\/journal.pone.0088772.","journal-title":"PLoS One"},{"issue":"3","key":"1064_CR93","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.yexmp.2009.09.001","volume":"87","author":"H Chen","year":"2009","unstructured":"Chen H, Yang WW, Wen QT, Xu L, Chen M. TGF-\u03b2-induced fibroblast activation protein expression, fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM. Exp Mol Pathol. 2009;87(3):189\u201394. https:\/\/doi.org\/10.1016\/j.yexmp.2009.09.001.","journal-title":"Exp Mol Pathol"},{"key":"1064_CR94","first-page":"10","volume":"5","author":"H Dolznig","year":"2005","unstructured":"Dolznig H, Schweifer N, Puri C, Kraut N, Rettig WJ, Kerjaschki D, et al. Characterization of cancer stroma markers: In silico analysis of an mRNA expression database for fibroblast activation protein and endosialin. Cancer Immun. 2005;5:10.","journal-title":"Cancer Immun"},{"issue":"1","key":"1064_CR95","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40364-020-00245-w","volume":"8","author":"C Han","year":"2020","unstructured":"Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomark Res. 2020;8(1):64. https:\/\/doi.org\/10.1186\/s40364-020-00245-w.","journal-title":"Biomark Res"},{"issue":"32","key":"1064_CR96","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37(32):4343\u201357. https:\/\/doi.org\/10.1038\/s41388-018-0275-3.","journal-title":"Oncogene"},{"issue":"5\u20136","key":"1064_CR97","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy. Proteomics - Clin Appl. 2014;8(5\u20136):454\u201363. https:\/\/doi.org\/10.1002\/prca.201300095.","journal-title":"Proteomics - Clin Appl"},{"issue":"20","key":"1064_CR98","doi-asserted-by":"publisher","first-page":"19441","DOI":"10.1074\/jbc.C500092200","volume":"280","author":"K Aertgeerts","year":"2005","unstructured":"Aertgeerts K, Levin I, Shi L, Snell GP, Jennings A, Prasad GS, et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein \u03b1. J Biol Chem. 2005;280(20):19441\u20134. https:\/\/doi.org\/10.1074\/jbc.C500092200.","journal-title":"J Biol Chem"},{"issue":"9","key":"1064_CR99","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1021\/jm400351a","volume":"56","author":"SE Poplawski","year":"2013","unstructured":"Poplawski SE, Lai JH, Li Y, Jin Z, Liu Y, Wu W, et al. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase. J Med Chem. 2013;56(9):3467\u201377. https:\/\/doi.org\/10.1021\/jm400351a.","journal-title":"J Med Chem"},{"issue":"4","key":"1064_CR100","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","volume":"107","author":"KN Lee","year":"2006","unstructured":"Lee KN, Jackson KW, Christiansen VJ, Lee CS, Chun JG, McKee PA. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood. 2006;107(4):1397\u2013404. https:\/\/doi.org\/10.1182\/blood-2005-08-3452.","journal-title":"Blood"},{"issue":"1","key":"1064_CR101","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1074\/mcp.RA118.001046","volume":"18","author":"HE Zhang","year":"2019","unstructured":"Zhang HE, Hamson EJ, Koczorowska MM, Tholen S, Chowdhury S, Bailey CG, et al. Identification of novel natural substrates of fibroblast activation protein-alpha by differential degradomics and proteomics. Mol Cell Proteomics. 2019;18(1):65\u201385. https:\/\/doi.org\/10.1074\/mcp.RA118.001046.","journal-title":"Mol Cell Proteomics"},{"issue":"14","key":"1064_CR102","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, et al. FAP Promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76(14):4124\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2973.","journal-title":"Cancer Res"},{"issue":"12","key":"1064_CR103","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1172\/JCI38988","volume":"119","author":"AM Santos","year":"2009","unstructured":"Santos AM, Jung J, Aziz N, Kissil JL, Pur\u00e9 E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009;119(12):3613\u201325. https:\/\/doi.org\/10.1172\/JCI38988.","journal-title":"J Clin Invest"},{"issue":"4","key":"1064_CR104","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1038\/cddis.2014.122","volume":"5","author":"H Wang","year":"2014","unstructured":"Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 2014;5(4):e1155. https:\/\/doi.org\/10.1038\/cddis.2014.122.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1064_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12781","volume":"185","author":"C Klemann","year":"2016","unstructured":"Klemann C, Wagner L, Stephan M, von H\u00f6rsten S. Cut to the chase: a review of CD26\/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system. Clin Exp Immunol. 2016;185(1):1\u201321. https:\/\/doi.org\/10.1111\/cei.12781.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1064_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.41058","volume":"72","author":"A Soare","year":"2020","unstructured":"Soare A, Gy\u00f6rfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, et al. Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis. Arthritis Rheumatol. 2020;72(1):137\u201349. https:\/\/doi.org\/10.1002\/art.41058.","journal-title":"Arthritis Rheumatol"},{"key":"1064_CR107","doi-asserted-by":"publisher","first-page":"552818","DOI":"10.3389\/fphar.2020.552818","volume":"11","author":"SY Lee","year":"2020","unstructured":"Lee SY, Wu ST, Liang YJ, Su MJ, Huang CW, Jao YH, et al. Soluble dipeptidyl peptidase-4 induces fibroblast activation through proteinase-activated receptor-2. Front Pharmacol. 2020;11:552818. https:\/\/doi.org\/10.3389\/fphar.2020.552818.","journal-title":"Front Pharmacol"},{"issue":"24","key":"1064_CR108","doi-asserted-by":"publisher","first-page":"21352","DOI":"10.1074\/jbc.m111663200","volume":"277","author":"SL Dallas","year":"2002","unstructured":"Dallas SL, Rosser JL, Mundy GR, Bonewald LF. Proteolysis of latent transforming growth factor-\u03b2 (TGF-\u03b2)-binding protein-1 by osteoclasts. J Biol Chem. 2002;277(24):21352\u201360. https:\/\/doi.org\/10.1074\/jbc.m111663200.","journal-title":"J Biol Chem"},{"issue":"3","key":"1064_CR109","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ki.2015.103","volume":"88","author":"S Shi","year":"2015","unstructured":"Shi S, Srivastava SP, Kanasaki M, He J, Kitada M, Nagai T, et al. Interactions of DPP-4 and integrin \u03b21 influences endothelial-to-mesenchymal transition. Kidney Int. 2015;88(3):479\u201389. https:\/\/doi.org\/10.1038\/ki.2015.103.","journal-title":"Kidney Int"},{"issue":"9","key":"1064_CR110","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/0008-5472.CAN-05-1245","volume":"66","author":"G Ghersi","year":"2006","unstructured":"Ghersi G, Zhao Q, Salamone M, Yeh Y, Zucker S, Chen WT. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res. 2006;66(9):4652\u201361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1245.","journal-title":"Cancer Res"},{"key":"1064_CR111","doi-asserted-by":"publisher","first-page":"CD012846","DOI":"10.1002\/14651858.CD012846","volume":"10","author":"R Hodgson","year":"2017","unstructured":"Hodgson R, BhaveChittawar P. Farquhar C 2017 GnRH agonists for uterine fibroids. Cochrane Database Syst Rev. 2017;10:CD012846. https:\/\/doi.org\/10.1002\/14651858.CD012846.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1064_CR112","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/0020-7292(92)90069-u","volume":"77","author":"AJ Friedman","year":"1991","unstructured":"Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. Obstet Gynecol. 1991;77(5):720\u20135. https:\/\/doi.org\/10.1016\/0020-7292(92)90069-u.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1064_CR113","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejogrb.2006.07.018","volume":"134","author":"JB Engel","year":"2007","unstructured":"Engel JB, Audebert A, Frydman R, Zivny J, Diedrich K. Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study. Eur J Obstet Gynecol Reprod Biol. 2007;134(2):225\u201332. https:\/\/doi.org\/10.1016\/j.ejogrb.2006.07.018.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"1064_CR114","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/nejmoa2008283","volume":"384","author":"A Al-Hendy","year":"2021","unstructured":"Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, Critchley HOD, et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N Engl J Med. 2021;384(7):630\u201342. https:\/\/doi.org\/10.1056\/nejmoa2008283.","journal-title":"N Engl J Med"},{"key":"1064_CR115","doi-asserted-by":"publisher","first-page":"1374821","DOI":"10.1155\/2018\/1374821","volume":"2018","author":"T Rabe","year":"2018","unstructured":"Rabe T, Saenger N, Ebert AD, Roemer T, Tinneberg HR, De Wilde RL, et al. Selective progesterone receptor modulators for the medical treatment of uterine fibroids with a focus on ulipristal acetate. Biomed Res Int. 2018;2018:1374821. https:\/\/doi.org\/10.1155\/2018\/1374821.","journal-title":"Biomed Res Int"},{"issue":"6","key":"1064_CR116","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ajog.2017.12.206","volume":"218","author":"SS Singh","year":"2018","unstructured":"Singh SS, Belland L, Leyland N, von Riedemann S, Murji A. The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids. Am J Obstet Gynecol. 2018;218(6):563-572.e1. https:\/\/doi.org\/10.1016\/j.ajog.2017.12.206.","journal-title":"Am J Obstet Gynecol"},{"key":"1064_CR117","doi-asserted-by":"publisher","first-page":"CD007687","DOI":"10.1002\/14651858.CD007687.pub2","volume":"8","author":"M Tristan","year":"2012","unstructured":"Tristan M, Orozco LJ, Steed A, Ramirez-Morera A. Stone P 2012 Mifepristone for uterine fibroids. Cochrane Database Syst Rev. 2012;8:CD007687. https:\/\/doi.org\/10.1002\/14651858.CD007687.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1064_CR118","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5114\/pm.2017.72792","volume":"16","author":"K Piecak","year":"2017","unstructured":"Piecak K, Milart P, Wozniakowska E, Paszkowski T. Ulipristal acetate as a treatment option for uterine fibroids. Prz Menopauzalny. 2017;16(4):133\u20136. https:\/\/doi.org\/10.5114\/pm.2017.72792.","journal-title":"Prz Menopauzalny"},{"issue":"1","key":"1064_CR119","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12325-020-01555-z","volume":"38","author":"E Ekanem","year":"2021","unstructured":"Ekanem E, Talaulikar V. Medical therapy for fibroids: what next for ulipristal acetate? Adv Ther. 2021;38(1):137\u201348. https:\/\/doi.org\/10.1007\/s12325-020-01555-z.","journal-title":"Adv Ther"},{"issue":"1","key":"1064_CR120","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1055\/s-2004-823027","volume":"22","author":"M Shozu","year":"2004","unstructured":"Shozu M, Murakami K, Inoue M. Aromatase and leiomyoma of the uterus. Semin Reprod Med. 2004;22(1):51\u201360. https:\/\/doi.org\/10.1055\/s-2004-823027.","journal-title":"Semin Reprod Med"},{"issue":"3","key":"1064_CR121","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jog.13847","volume":"45","author":"F Wang","year":"2019","unstructured":"Wang F, Zhang ZF, He YR, Wu HY, Wei SS. Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-\u03b21 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats. J Obstet Gynaecol Res. 2019;45(3):600\u20138. https:\/\/doi.org\/10.1111\/jog.13847.","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"1064_CR122","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","volume":"49","author":"K Kaji","year":"2014","unstructured":"Kaji K, Yoshiji H, Ikenaka Y, Noguchi R, Aihara Y, Douhara A, et al. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol. 2014;49(3):481\u201391. https:\/\/doi.org\/10.1007\/s00535-013-0783-4.","journal-title":"J Gastroenterol"},{"issue":"8","key":"1064_CR123","doi-asserted-by":"publisher","first-page":"e0160993","DOI":"10.1371\/journal.pone.0160993","volume":"11","author":"T Nagai","year":"2016","unstructured":"Nagai T, Doi S, Nakashima A, Irifuku T, Sasaki K, Ueno T, et al. Linagliptin ameliorates methylglyoxal-induced peritoneal fibrosis in mice. PLoS One. 2016;11(8):e0160993. https:\/\/doi.org\/10.1371\/journal.pone.0160993.","journal-title":"PLoS One"},{"issue":"6","key":"1064_CR124","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.kint.2019.01.010","volume":"95","author":"AA Hasan","year":"2019","unstructured":"Hasan AA, Von WK, Reichetzeder C, Tsuprykov O, Gaballa MMS, Guo J, et al. Mechanisms of GLP-1 receptor\u2013independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5\/6 nephrectomy. Kidney Int. 2019;95(6):1373\u201388. https:\/\/doi.org\/10.1016\/j.kint.2019.01.010.","journal-title":"Kidney Int"},{"issue":"3","key":"1064_CR125","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbagen.2017.11.012","volume":"1862","author":"AP Marques","year":"2018","unstructured":"Marques AP, Cunha-Santos J, Leal H, Sousa-Ferreira L, de Pereira AL, Cavadas C, et al. Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice. Biochim Biophys Acta - Gen Subj. 2018;1862(3):403\u201313. https:\/\/doi.org\/10.1016\/j.bbagen.2017.11.012.","journal-title":"Biochim Biophys Acta - Gen Subj"},{"issue":"3","key":"1064_CR126","doi-asserted-by":"publisher","first-page":"e0119360","DOI":"10.1371\/journal.pone.0119360","volume":"10","author":"H Hirakawa","year":"2015","unstructured":"Hirakawa H, Zempo H, Ogawa M, Watanabe R, Suzuki JI, Akazawa H, et al. A DPP-4 inhibitor suppresses fibrosis and inflammation on experimental autoimmune myocarditis in mice. PLoS One. 2015;10(3):e0119360. https:\/\/doi.org\/10.1371\/journal.pone.0119360.","journal-title":"PLoS One"},{"issue":"6","key":"1064_CR127","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1113\/EP085108","volume":"100","author":"T Inthachai","year":"2015","unstructured":"Inthachai T, Lekawanvijit S, Kumfu S, Apaijai N, Pongkan W, Chattipakorn SC, et al. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction. Exp Physiol. 2015;100(6):667\u201379. https:\/\/doi.org\/10.1113\/EP085108.","journal-title":"Exp Physiol"},{"issue":"6","key":"1064_CR128","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/db13-1029","volume":"63","author":"K Kanasaki","year":"2014","unstructured":"Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, et al. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes. 2014;63(6):2120\u201331. https:\/\/doi.org\/10.2337\/db13-1029.","journal-title":"Diabetes"},{"key":"1064_CR129","doi-asserted-by":"publisher","first-page":"e922644","DOI":"10.12659\/MSM.922644","volume":"26","author":"X Liu","year":"2020","unstructured":"Liu X, Zhang T, Zhang C. Sitagliptin inhibits extracellular matrix accumulation and proliferation in lung fibroblasts. Med Sci Monit. 2020;26:e922644.","journal-title":"Med Sci Monit"},{"issue":"1","key":"1064_CR130","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12931-017-0660-4","volume":"18","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, et al. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res. 2017;18(1):177. https:\/\/doi.org\/10.1186\/s12931-017-0660-4.","journal-title":"Respir Res"},{"issue":"4","key":"1064_CR131","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.jid.5701104","volume":"128","author":"A Thielitz","year":"2008","unstructured":"Thielitz A, Vetter RW, Schultze B, Wrenger S, Simeoni L, Ansorge S, et al. Inhibitors of dipeptidyl peptidase IV-like activity mediate anti-fibrotic effects in normal and keloid-derived skin fibroblasts. J Invest Dermatol. 2008;128(4):855\u201366. https:\/\/doi.org\/10.1038\/sj.jid.5701104.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"1064_CR132","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1039\/c4md00167b","volume":"5","author":"K Jansen","year":"2014","unstructured":"Jansen K, De WH, Heirbaut L, Cheng JD, Joossens J, Lambeir AM, et al. Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold. Medchemcomm. 2014;5(11):1700\u20137. https:\/\/doi.org\/10.1039\/c4md00167b.","journal-title":"Medchemcomm"},{"issue":"11","key":"1064_CR133","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1002\/cam4.3024","volume":"9","author":"Q Wang","year":"2020","unstructured":"Wang Q, Lu P, Wang T, Zheng Q, Li Y, Leng SX, et al. Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma-associated antigen-A3 expression through Yes-associated protein inactivation. Cancer Med. 2020;9(11):3816\u201328. https:\/\/doi.org\/10.1002\/cam4.3024.","journal-title":"Cancer Med"},{"issue":"1","key":"1064_CR134","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12933-017-0544-4","volume":"16","author":"AR Aroor","year":"2017","unstructured":"Aroor AR, Habibi J, Kandikattu HK, Garro-Kacher M, Barron B, Chen D, et al. Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice. Cardiovasc Diabetol. 2017;16(1):61. https:\/\/doi.org\/10.1186\/s12933-017-0544-4.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-01064-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T19:08:06Z","timestamp":1683227286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-01064-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":134,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-01064-0","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical consents do not apply to this study since the study did not involve animal or human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have given their consent to publish the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}